ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Bioorganic & Medicinal Chemistry Letters
Volume 15, Issue 6, 15 March 2005, Pages 1595-1598
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (128 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bmcl.2005.01.065    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Ltd All rights reserved.

Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol

Cledir Santosa, Maria Luísa Mateusb, Ana Paula dos Santosb, Rui Moreirab, Eliandre de Oliveirac and Paula Gomesa, Corresponding Author Contact Information, E-mail The Corresponding Author

aCIQUP, Departamento de Química, Faculdade de Ciências do Porto, P-4169-007 Porto, Portugal bCECF, Faculdade de Farmácia de Lisboa, P-1600-083 Lisboa, Portugal cProteomics Platform, Barcelona Science Park, E-08028 Barcelona, Spain

Received 2 December 2004; 
revised 21 January 2005; 
accepted 27 January 2005. 
Available online 19 February 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Dipeptide esters of paracetamol were prepared in high yields. These compounds are quantitatively hydrolyzed to paracetamol and corresponding 2,5-diketopiperazines at pH 7.4 and 37 °C. The reactivity is increased in sarcosine and proline peptides and decreased by bulky side chains at both the N- and C-terminal residues of the dipeptide carrier. Moreover, dipeptide esters of paracetamol did not affect the levels of hepatic glutathione. Thus, dipeptides seem promising candidates as carriers for cyclization-activated prodrugs.

Graphical abstract

Dipeptide esters of paracetamol were prepared and observed to be quantitatively hydrolyzed to paracetamol and 2,4-diketopiperazines at pH 7.4 and 37 °C. Hydrolysis rates depended on dipeptide structure. These novel compounds do not affect the levels of hepatic glutathione.


Keywords: Cyclization-activated; Paracetamol; Peptide carrier; Prodrug

Article Outline

Acknowledgements
References





 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.